Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · IEX Real-Time Price · USD
2.890
-0.240 (-7.67%)
At close: Jun 18, 2024, 4:00 PM
2.900
+0.010 (0.35%)
After-hours: Jun 18, 2024, 4:09 PM EDT

Werewolf Therapeutics Revenue

Werewolf Therapeutics had revenue of $16.22M in the twelve months ending March 31, 2024, down -22.26% year-over-year. Revenue in the quarter ending March 31, 2024 was $742.00K, a -83.38% decrease year-over-year. In the year 2023, Werewolf Therapeutics had annual revenue of $19.94M with 21.60% growth.

Revenue (ttm)
$16.22M
Revenue Growth
-22.26%
P/S Ratio
7.74
Revenue / Employee
$352,630
Employees
46
Market Cap
125.59M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202319.94M3.54M21.60%
Dec 31, 202216.40M--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Harvard Bioscience 106.79M
TELA Bio 63.15M
Electromed 53.50M
Sagimet Biosciences 2.00M
aTyr Pharma 588.00K
Revenue Rankings